CellSeed Inc. (7776.T)
JPY 408.0
(-7.69%)
JPY 408.0
(-7.69%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 46.19 Million JPY | -17.76% |
| 2022 | 56.16 Million JPY | 35.22% |
| 2021 | 41.53 Million JPY | -2.75% |
| 2020 | 42.71 Million JPY | -11.02% |
| 2019 | 48 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 48.74 Million JPY | 6.23% |
| 2024 Q1 | 45.88 Million JPY | -0.67% |
| 2023 Q2 | 58.92 Million JPY | 2.41% |
| 2023 Q4 | 46.19 Million JPY | -16.84% |
| 2023 Q1 | 57.53 Million JPY | 2.44% |
| 2023 FY | 46.19 Million JPY | -17.76% |
| 2023 Q3 | 55.54 Million JPY | -5.73% |
| 2022 Q3 | 65.32 Million JPY | 0.0% |
| 2022 FY | 56.16 Million JPY | 35.22% |
| 2022 Q4 | 56.16 Million JPY | -14.02% |
| 2021 FY | 41.53 Million JPY | -2.75% |
| 2020 FY | 42.71 Million JPY | -11.02% |
| 2019 FY | - JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | 93.237% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -157.633% |
| GNI Group Ltd. | 2.33 Billion JPY | 98.018% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 97.927% |
| MEDINET Co., Ltd. | 67.48 Million JPY | 31.55% |
| Soiken Holdings Inc. | 1.12 Billion JPY | 95.879% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | 55.386% |
| AnGes, Inc. | 1.61 Billion JPY | 97.141% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | 37.579% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 98.409% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | 85.651% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -25003.804% |
| Carna Biosciences, Inc. | 140.14 Million JPY | 67.039% |
| CanBas Co., Ltd. | 728 Thousand JPY | -6244.918% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | 47.428% |
| RaQualia Pharma Inc. | 147.93 Million JPY | 68.777% |
| Chiome Bioscience Inc. | 64.1 Million JPY | 27.947% |
| Kidswell Bio Corporation | 875.65 Million JPY | 94.725% |
| PeptiDream Inc. | 2.4 Billion JPY | 98.079% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -764.676% |
| Ribomic Inc. | 2.27 Million JPY | -1931.266% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -4619099900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | -28.308% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | -59.279% |
| CellSource Co., Ltd. | 305.92 Million JPY | 84.901% |
| FunPep Company Limited | 25.54 Million JPY | -80.85% |
| Kringle Pharma, Inc. | 364.05 Million JPY | 87.312% |
| Stella Pharma Corporation | 1.11 Billion JPY | 95.862% |
| TMS Co., Ltd. | 50.02 Million JPY | 7.664% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | -120.999% |
| Cuorips Inc. | 1.04 Million JPY | -4328.667% |
| K Pharma,Inc. | 10.79 Million JPY | -327.932% |
| Takara Bio Inc. | 11.85 Billion JPY | 99.61% |
| ReproCELL Incorporated | 248.14 Million JPY | 81.385% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | 89.749% |
| StemCell Institute Inc. | 42.26 Million JPY | -9.297% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | 79.791% |